Litcius/Paper detail

Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation

Guohui Zhong, Jie Guo, Chengyun Pang, Di Su, Chunli Tang, Lin Jing, Fengling Zhang, Pingnian He, Yaqian Yan, Zongji Chen, Jing Liu, Neng Jiang

2022Bioorganic Chemistry21 citationsDOI

Topics & Concepts

IC50ChemistryMonoamine oxidaseCholinesteraseAchéAcetylcholinesterasePharmacologyMonoamine oxidase BToxicityInhibitory postsynaptic potentialPotencyMonoamine neurotransmitterIn vitroEnzymeBiochemistryInternal medicineMedicineReceptorSerotoninOrganic chemistryCholinesterase and Neurodegenerative DiseasesMedicinal Plants and NeuroprotectionAlzheimer's disease research and treatments
Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation | Litcius